NCT04554979View on ClinicalTrials.gov

COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience

CompletedOBSERVATIONAL

Enrollment

199

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions

Covid19Diarrhea

Interventions

DRUG

Hydroxychloroquine Pill

hydroxychloroquine 400 mg twice daily first day and maintained on 200 mg twice daily for 6 days in mild cases and 10 days in moderate cases. Also they received anticoagulants, vitamin c and zinc. In case of secondary bacterial infection, empiric antibiotics are started

Trial Locations (1)

Unknown

Faculty of Medicine Cairo University, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT04554979 - COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience | Biotech Hunter | Biotech Hunter